Table 2.
Efficacy and safety comparison between tissue gel, coil, and combination groups.
| Characteristics | Total (n = 60) | Tissue gel group (A) (n = 30) | Combination group (B) (n = 10) | Coil group (C) (n = 20) | P |
|---|---|---|---|---|---|
| Rebleeding 12 M after TIPS | 7 (11.7%) | 3 (10.0%) | 0 | 4 (20.0%) | 0.254a |
| Rebleeding 3 M after TIPS | 3 (5.0%) | 3 (10.0%) | 0 | 0 | 0.277a |
| Rebleeding 3~6 M after TIPS | 2 (3.3%) | 0 | 0 | 2 (10.0%) | 0.133a |
| Rebleeding 6–12 M after TIPS | 2 (3.3%) | 0 | 0 | 2 (10.0%) | 0.133a |
| Died 12 M after TIPS | 6 (10.0%) | 3 (10.0%) | 0 | 3 (15.0%) | 0.533a |
| Died 3 M after TIPS | 3 (5.0%) | 3 (10.0%) | 0 | 0 | 0.277a |
| Died 3~6 M after TIPS | 2 (3.3%) | 0 | 0 | 2 (10.0%) | 0.133a |
| Died 6–12 M after TIPS | 1 (1.7%) | 0 | 0 | 1 (5.0%) | 0.500a |
| Charge of Embolic Agents ($) | 637.6 | 310.5 | 950.8 | 974.6 | <0.001- |
| Complications | 14 (23.3%) | 10 (33.3%) | 1 (10.0%) | 3 (15.0%) | 0.244a |
| Overt HE | 9 (15.0%) | 6 (20.0%) | 0 | 3 (15.0%) | 0.440a |
| Shunt dysfunction | 2 (3.3%) | 1 (3.3%) | 0 | 1 (5.0%) | 1.00a |
TIPS = transjugular intrahepatic portosystemic shunt. HE = hepatic encephalopathy.
a
Fisher test; - Kruskal-Wallis test.